← Back to Drug List

ACECLIDINE SOLN,OPH

Clinical Criteria Summary

Indication

  • Presbyopia

Patient Population & Clinical Characteristics

  • Adults aged 45-75 years of either sex
  • Refractive range from -4.00 to +1.00 D sphere
  • Astigmatism up to 2.00 D
  • Spherical equivalent no more myopic than -4.00 D

Administration & Dosing

  • Ophthalmic solution: aceclidine 1.44% in a single-dose vial
  • Instill 1 drop in each eye, wait 2 minutes and instill a second drop in each eye once daily from the same single-dose vial
  • Contact lenses should be removed prior to aceclidine administration

Contraindications

  • None explicitly stated

Warnings & Precautions

  • Blurred vision
  • Risk of retinal tear/detachment
  • Iritis
  • Hypersensitivity
  • Potential for eye injury and contamination

Exclusion Criteria

  • Female of childbearing potential who is currently pregnant, nursing, or planning a pregnancy
  • Known contraindications or sensitivity to the use of any study medications or their components
  • Active ocular infection, positive history of an ocular herpetic infection, preauricular lymphadenopathy, or ongoing active ocular inflammation
  • Moderate or severe dry eye
  • Clinically significant abnormal lens findings

Source Documents